RxDoctor Payments Data

Natalie Erickson, PA

Physician Assistant · Sheboygan, WINPI 1194433565

Payments from drug & device makers

$643in general payments, 2019–2025

Across 26 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$142
  • Lilly USA, LLC$125
  • Johnson & Johnson$115
  • Pfizer$67
  • AstraZeneca$52
  • Novo Nordisk$34
  • plus $108 from 6 others

What the payments were for

  • Food & beverage$643100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$643 in reported general payments places this provider in the 80th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$22,924
Medicare patients
100
Services billed
785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$100,108
JardianceEmpagliflozin83$86,021
TrulicityDulaglutide24$23,250
RybelsusSemaglutide11$22,029
EliquisApixaban18$15,446
Breo ElliptaFluticasone/Vilanterol17$7,465
Synjardy XrEmpagliflozin/Metformin Hcl12$6,772
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$2,839
Nano 2nd Gen Pen NeedlePen Needle, Diabetic11$1,358
Atorvastatin Calcium155$1,283
Potassium Chloride37$961
Albuterol Sulfate HfaAlbuterol Sulfate33$825
Levothyroxine Sodium88$812
Pantoprazole Sodium54$686
Metformin Hcl71$653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$34$122,13797 claims
Lilly USA, LLCTrulicity$125$23,25024 claims
PfizerEliquis$67$15,44618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Sheboygan

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →